Daily Judi: Monday, September 26, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
The Advocate examines the enrollment difficulties and challenges faced by clinical trials for Alzheimer’s disease.
Capstan Therapeutics, a new venture launched out of the University of Pennsylvania, received a $165 million seed-round investment, co-led by Pfizer and Novartis, to create therapies for autoimmune disease and other disorders. (FirstWord Pharma)
As guest columnists for Clinical Leader, Liisa M. Eisenlohr and Enno Behrendt discuss how to employ real-world data in developing new therapeutics—without violating privacy laws.
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team Judi will be there!
Our Culture
“We work proactively with each client, analyzing our reports to make them work faster, to help make our client’s life better.”
–Tim, Trial Delivery
About Judi
Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
